Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
|---|---|---|---|---|---|
| ALL-HR2H3 | Human | HRP-Human ALPL Protein, His Tag |  |
|
|
| ALL-H52H3 | Human | Human ALPL Protein, His Tag (active enzyme, MALS verified) |  |
|
The purity of Human ALPL Protein, His Tag (Cat. No. ALL-H52H3) is more than 90% and the molecular weight of this protein is around 115-135 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Asfotase alfa | sTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040 | Approved | Alexion Pharmaceuticals Inc | Strensiq | Japan | Hypophosphatasia | Alexion Pharmaceuticals Inc | 2015-07-03 | Hypophosphatasia | Details |
| Asfotase alfa | sTNALP-FcD10; ALXN-1215; sALP-FcD10; ENB-0040 | Approved | Alexion Pharmaceuticals Inc | Strensiq | Japan | Hypophosphatasia | Alexion Pharmaceuticals Inc | 2015-07-03 | Hypophosphatasia | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ALXN-1850 | ALXN-1850 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
| DS-1211 | DS-1211 | Phase 2 Clinical | Sanford Burnham Prebys Medical Discovery Institute, Daiichi Sankyo Co Ltd | Ossification, Heterotopic; Pseudoxanthoma Elasticum | Details |
| ALXN-1910 | ALXN-1910 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Details | |
| ALXN-1850 | ALXN-1850 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
| DS-1211 | DS-1211 | Phase 2 Clinical | Sanford Burnham Prebys Medical Discovery Institute, Daiichi Sankyo Co Ltd | Ossification, Heterotopic; Pseudoxanthoma Elasticum | Details |
| ALXN-1910 | ALXN-1910 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Details |
This web search service is supported by Google Inc.
A-Z
